Introduzione
WuXi Biologics Inc. is an investment holding company primarily engaged in providing end-to-end solutions and services for the discovery, development, and manufacturing of biological products to clients in the biopharmaceutical industry. The company operates primarily through two segments: the Biopharmaceuticals segment focuses on the discovery, development, and manufacturing of biologics; and the WuXi Consortium (XDC) segment provides contract research, development, and manufacturing organization (CRDMO) services for antibody-drug conjugates (ADCs) and various biodrug conjugates. The company primarily operates in domestic and international markets.
